GR181413A/AT1001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GR181413A/AT1001, covering 2013-12-18 to 2013-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy Japanese Subjects [Phase 1]